B. Riley Financial Varied
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Awakn Life Sciences Corp (OP: AWKNF )

0.2500 UNCHANGED
Streaming Delayed Price Updated: 2:28 PM EST, Jan 27, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 11,220
Open 0.2593
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.2500
Today's Range 0.2319 - 0.2593
52wk Range 0.1701 - 1.680
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Two New Studies On Classical Psychedelics: Grading Ketamine's Components, Tuning Down Psilocybin Dosing
Awakn’s First Study On Novel S-Ketamine Formulation To Assess Dissociative Effect 
Via Benzinga
What Happened With Psychedelics In The Last Year? 11 Key News Items, The Sector's Performance & Takeaways
What a year for psychedelics! 
Via Benzinga

Performance

YTD
+8.70%
+8.70%
1 Month
-14.21%
-14.21%
3 Month
+1.71%
+1.71%
6 Month
-54.55%
-54.55%
1 Year
-84.18%
-84.18%

More News

Read More
6 Largest Psychedelic Drug Stocks Were -20% In December
Via Talk Markets
Largest Psychedelic Stocks DOWN 8% Last Week; DOWN 22% So Far This Month
Via Talk Markets
Psyched: First Ayahuasca Pill Created, Psychedelics Legalization Predicted, UK's Research Support And More
Via Benzinga
Awakn Unveils Q3 Results, Touts Revenue Growth, R&D Progress, Commercial Plans
Via Benzinga
UK Supports Psychedelic Research With Phase 3 Trial In Federal Health Sites
Via Benzinga
Major Psychedelic Drug Stocks DOWN 9% Last Week; Now Down 51% YTD
Via Talk Markets
Psyched: Fed Guidelines And Research Production Quotas, Protests In Canada, Cal's Decrim Project
Via Benzinga
Europe To Have Expanded Access To Psychedelic-Assisted Therapy With New Norway Clinic
Via Benzinga
Psyched: Full-Dose & Microdosing LSD Studies, Research Scope For Fed Funding, Consumption Sites And More
Via Benzinga
Psychedelic Drug Stocks Index Has A Good Week
Via Talk Markets
A Leading Ketamine Treatment Clinic For Alcoholism Is Expanding: Here's The Latest
Via Benzinga
Psychedelic Drug Stocks Index Continued To Decline Last Week
Via Talk Markets
Psyched: Colorado Legalizes Psychedelics, NYC Treats Alcoholism With Ketamine, $30M Series A For Startup
Via Benzinga
EXCLUSIVE: New Partnership Brings Leading Psychedelic Protocol For Alcoholism Treatment To NYC
Via Benzinga
Can Ketamine Treat Alcohol Addiction? In-Clinic Therapy Vs. Retreats
Via Benzinga
Can Ketamine Treat Alcohol Addiction? The Awakn Approach
Via Benzinga
Psychedelic Drug Stocks Index Up Slightly This Week
Via Talk Markets
Can Ketamine Treat Alcohol Addiction? How Therapy Actually Functions?
Via Benzinga
Can Ketamine Treat Alcohol Addiction? Clinics & Hospitals In Europe And North America Are Already Doing It
Via Benzinga
Awakn And Catalent's Partnership Could Provide Hope For People Suffering From Addiction
Via Benzinga
Psychedelic Stocks Continue To Plummet: -16% This Week; -33% MTD; Now -57% YTD
Via Talk Markets
8 Largest Psychedelic Stocks Continued Their Decline Last Week
Via Talk Markets
Awakn Shares Its Q2 2022 Results, Showing Consistent Growth On Its Second Full Financial Year
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
B. Riley Financial's diverse suite of services goes beyond traditional financial service offerings. By leveraging cross-platform expertise and assets, B. Riley Financial companies are uniquely positioned to provide full service, collaborative solutions to our clients at every stage of the business life cycle and in all market conditions.

B. Riley refers to B. Riley Financial, Inc. and/or one or more of its subsidiaries or affiliates. Click here for further details.